Nearly 17M U.S. Teens, Young Adults Eligible for GLP-1 Agonists

By News Health
4 hours Ago

(MedPage Today) — Though an estimated 17 million U.S. adolescents and young adults were eligible for GLP-1 receptor agonists for conditions like obesity and type 2 diabetes, many lacked insurance or a routine place for healthcare, a cross-sectional…

Source link : https://www.medpagetoday.com/pediatrics/generalpediatrics/116821

Author :

Publish date : 2025-08-04 20:03:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Did FDA Pick the Wrong COVID Vaccine Strain Last Season?

Tamiflu Findings Raise Questions About Drug Label Warning for Kids

CDC Urged to Preserve Funding for Overdose Prevention

Weight Loss Diet Not Needed With Exercise for Hip OA Pain

Low-Cal Diet Plus Exercise May Help Patients With Hip OA

Novel T1D Therapy Opens the Door to Cell Transplants Sans Immunosuppressants